Compare PEN & WMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PEN | WMG |
|---|---|---|
| Founded | 2004 | 1929 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8B | 14.4B |
| IPO Year | 2015 | 2005 |
| Metric | PEN | WMG |
|---|---|---|
| Price | $325.75 | $28.08 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 16 | 13 |
| Target Price | ★ $360.14 | $36.38 |
| AVG Volume (30 Days) | 476.6K | ★ 1.6M |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.72% |
| EPS Growth | ★ 1155.56 | N/A |
| EPS | ★ 4.52 | N/A |
| Revenue | $1,403,665,000.00 | ★ $4,463,000,000.00 |
| Revenue This Year | $14.34 | $7.20 |
| Revenue Next Year | $13.71 | $5.99 |
| P/E Ratio | $72.14 | ★ N/A |
| Revenue Growth | ★ 17.50 | N/A |
| 52 Week Low | $221.26 | $23.34 |
| 52 Week High | $362.41 | $34.63 |
| Indicator | PEN | WMG |
|---|---|---|
| Relative Strength Index (RSI) | 38.65 | 49.29 |
| Support Level | $302.19 | $26.59 |
| Resistance Level | $335.61 | $30.78 |
| Average True Range (ATR) | 2.94 | 0.77 |
| MACD | -0.33 | -0.18 |
| Stochastic Oscillator | 15.04 | 26.02 |
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.
Warner Music is the third-largest of the three major record companies. Recorded music accounts for most of the firm's revenue, with the segment housing notable record labels including Atlantic Records, Warner Records, Elektra Records. Some of the most successful current artists signed to record deals with Warner include Ed Sheeran, Bruno Mars, Cardi B, and Dua Lipa. Warner's remaining revenue comes from its publishing business, where Warner Chappell represents more than 180,000 songwriters and composers, some of whom are also Warner recording artists but many of whom are not recording artists or are attached to other labels. Warner Chappell controls more than 1 million musical compositions. Access Industries controls 98% of Warner's voting rights, while holding a 72% economic interest.